Published in

MDPI, Pharmaceuticals, 10(3), p. 3343-3354, 2010

DOI: 10.3390/ph3103343

Links

Tools

Export citation

Search in Google Scholar

Anti-Viral Drugs for Human Adenoviruses

Journal article published in 2010 by Mary Miu Yee Waye, Chor Wing Sing ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

There are many stages in the development of a new drug for viral infection and such processes are even further complicated for adenovirus by the fact that there are at least 51 serotypes, forming six distinct groups (A–F), with different degree of infectivity. This review attempts to address the importance of developing pharmaceuticals for adenovirus and also review recent development in drug discovery for adenovirus, including newer strategies such as microRNA approaches. Different drug screening strategies will also be discussed.